S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Kitasato University · Osaka Medical Center for Cancer and Cardiovascular Diseases · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,868
total citations
- FWCI
- 90.34
- Percentile
- 100%
- References
- 29
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Medicine
- Cisplatin
- Clinical endpoint
- Cancer
- Chemotherapy
- Internal medicine
- Clinical trial
- Phases of clinical research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.